Patient Scenario 2: Second-Line Management of RR DTC With Cabozantinib
Moving on to a new clinical scenario, Lori Wirth, MD, reviews the second-line management of a patient who progresses on frontline systemic therapy.
Lori Wirth Treatment Approaches Sequencing Strategies Differentiated Thyroid Cancer Second Line Management Thyroid Cancer
Source: onclive.com